• Mashup Score: 1

    Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve…

    Tweet Tweets with this article
    • RT @Open_HeartBMJ: Hidden Burden of Severe Aortic Stenosis Far Exceeds Current NHS Capacity #OpenHeartBMJ https://t.co/3BzIUXLZCO https…

  • Mashup Score: 2

    Your PrivacyWe process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the…

    Tweet Tweets with this article
    • Thank you to our reviewers #OpenHeartBMJ editors would like to publicly acknowledge people who served as reviewers on journal during 2021. Without their efforts, the quality of the journal could not be sustained. https://t.co/jNeZr7iGUY https://t.co/A1v5iW4ZeV

  • Mashup Score: 2

    Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve…

    Tweet Tweets with this article
    • ~300,000 people in UK have aortic stenosis NHS will struggle to cope with this volume, which is set to rise as population ages More than half of advanced cases will die within 5 yrs without proactive treatment #OpenHeartBMJ https://t.co/3BzIUXLZCO https://t.co/EPmBGlkJIh https://t.co/fqhJh1schG

  • Mashup Score: 0

    Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve…

    Tweet Tweets with this article
    • @DrPascalMeier @ncurzen @SukhNijjer @DrDerekConnolly @DrSarahClarke @VijayKunadian @PlayfordDavid @BritishCardioSo @UkValve #TAVI #TAVR #OpenHeartBMJ https://t.co/FSzyvN1JEG https://t.co/ByW8u7PQFv

  • Mashup Score: 0

    Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve…

    Tweet Tweets with this article
    • Hidden Burden of Severe Aortic Stenosis Far Exceeds Current NHS Capacity #OpenHeartBMJ https://t.co/3BzIUXLZCO https://t.co/8hL6QQtufh

  • Mashup Score: 2

    Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve…

    Tweet Tweets with this article
    • About 300,000 people in the UK have aortic valve stenosis, suggests research published in #OpenHeartBMJ https://t.co/3BzIUXLZCO https://t.co/KO9Uu034jD

  • Mashup Score: 0

    Background Percutaneous coronary intervention (PCI), the preferred coronary reperfusion strategy, induces endothelial trauma which may mount an inflammatory response. This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE). Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. We aimed to perform…

    Tweet Tweets with this article
    • #Colchicine for symptomatic #CAD after percutaneous coronary intervention #PCI Systematic review & meta-analysis of 7 RCTs including 6,660 patients shows a significant reduction in MACE #OpenHeartBMJ @OUHospitals https://t.co/dmlhGMN5iS https://t.co/GIpJ6e4qcu

  • Mashup Score: 5

    Transcatheter aortic valve replacement (TAVR) was born as a last resort for otherwise inoperable patients with symptomatic severe aortic stenosis (AS).1 Initially, the procedure was invasive, associated with serious complications and expensive, but if successful, offered patients with few treatment options the opportunity for improved survival and enhanced quality of life (QoL). Among elderly…

    Tweet Tweets with this article
    • Transcatheter aortic valve replacement #TAVR #TAVI: When should we say no? #OpenHeartBMJ @Mattialunardi @dmylotte https://t.co/5DcVqWhY2k https://t.co/aZ7BgMcCDZ